Sarah H Yi1, John A Jernigan2, L Clifford McDonald2. 1. Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA. Electronic address: sarahyi@cdc.gov. 2. Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Abstract
BACKGROUND: To inform clinical guidance, public health efforts, and research directions, probiotic use in U.S. health care needs to be better understood. This work aimed to assess the prevalence of inpatient probiotic use in a sample of U.S. hospitals. METHODS: Probiotic use among patients discharged in 2012 was estimated using the MarketScan Hospital Drug Database. In addition, the annual trend in probiotic use (2006-2012) was assessed among a subset of hospitals. RESULTS: Among 145 hospitals with 1,976,167 discharges in 2012, probiotics were used in 51,723 (2.6%) of hospitalizations occurring in 139 (96%) hospitals. Patients receiving probiotics were 9 times more likely to receive antimicrobials (P < .0001) and 21 times more likely to have a Clostridium difficile infection diagnosis (P < .0001). The most common probiotic formulations were Saccharomyces boulardii (32% of patients receiving probiotics), Lactobacillus acidophilus and Lactobacillus bulgaricus (30%), L acidophilus (28%), and Lactobacillus rhamnosus (11%). Probiotic use increased from 1.0% of 1,090,373 discharges in 2006 to 2.9% of 1,006,051 discharges in 2012 (P < .0001). CONCLUSIONS: In this sample of U.S. hospitals, a sizable and growing number of inpatients received probiotics as part of their care despite inadequate evidence to support their use in this population. Additional research is needed to guide probiotic use in the hospital setting. Published by Elsevier Inc.
BACKGROUND: To inform clinical guidance, public health efforts, and research directions, probiotic use in U.S. health care needs to be better understood. This work aimed to assess the prevalence of inpatient probiotic use in a sample of U.S. hospitals. METHODS: Probiotic use among patients discharged in 2012 was estimated using the MarketScan Hospital Drug Database. In addition, the annual trend in probiotic use (2006-2012) was assessed among a subset of hospitals. RESULTS: Among 145 hospitals with 1,976,167 discharges in 2012, probiotics were used in 51,723 (2.6%) of hospitalizations occurring in 139 (96%) hospitals. Patients receiving probiotics were 9 times more likely to receive antimicrobials (P < .0001) and 21 times more likely to have a Clostridium difficileinfection diagnosis (P < .0001). The most common probiotic formulations were Saccharomyces boulardii (32% of patients receiving probiotics), Lactobacillus acidophilus and Lactobacillus bulgaricus (30%), L acidophilus (28%), and Lactobacillus rhamnosus (11%). Probiotic use increased from 1.0% of 1,090,373 discharges in 2006 to 2.9% of 1,006,051 discharges in 2012 (P < .0001). CONCLUSIONS: In this sample of U.S. hospitals, a sizable and growing number of inpatients received probiotics as part of their care despite inadequate evidence to support their use in this population. Additional research is needed to guide probiotic use in the hospital setting. Published by Elsevier Inc.
Authors: James Baggs; John A Jernigan; Alison Laufer Halpin; Lauren Epstein; Kelly M Hatfield; L Clifford McDonald Journal: Clin Infect Dis Date: 2018-03-19 Impact factor: 9.079
Authors: Sarah H Yi; Kelly M Hatfield; James Baggs; Lauri A Hicks; Arjun Srinivasan; Sujan Reddy; John A Jernigan Journal: Clin Infect Dis Date: 2018-04-17 Impact factor: 9.079
Authors: Jennie Johnstone; Maureen Meade; François Lauzier; John Marshall; Erick Duan; Joanna Dionne; Yaseen M Arabi; Diane Heels-Ansdell; Lehana Thabane; Daphnee Lamarche; Michael Surette; Nicole Zytaruk; Sangeeta Mehta; Peter Dodek; Lauralyn McIntyre; Shane English; Bram Rochwerg; Tim Karachi; William Henderson; Gordon Wood; Daniel Ovakim; Margaret Herridge; John Granton; M Elizabeth Wilcox; Alberto Goffi; Henry T Stelfox; Daniel Niven; John Muscedere; François Lamontagne; Frédérick D'Aragon; Charles St-Arnaud; Ian Ball; Dave Nagpal; Martin Girard; Pierre Aslanian; Emmanuel Charbonney; David Williamson; Wendy Sligl; Jan Friedrich; Neill K Adhikari; François Marquis; Patrick Archambault; Kosar Khwaja; Arnold Kristof; James Kutsogiannis; Ryan Zarychanski; Bojan Paunovic; Brenda Reeve; François Lellouche; Paul Hosek; Jennifer Tsang; Alexandra Binnie; Sébastien Trop; Osama Loubani; Richard Hall; Robert Cirone; Steve Reynolds; Paul Lysecki; Eyal Golan; Rodrigo Cartin-Ceba; Robert Taylor; Deborah Cook Journal: JAMA Date: 2021-09-21 Impact factor: 56.272
Authors: Jesse M Bell; Tina M Mason; Harleah G Buck; Cindy S Tofthagen; Allyson R Duffy; Maureen W Groër; James P McHale; Kevin E Kip Journal: Clin Nurs Res Date: 2020-11-20 Impact factor: 2.075